Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Long term continuation with repeated Botulinum toxin A injections in people with neurogenic detrusor overactivity after spinal cord injury

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Epidemiological characteristics and early complications after spinal cord injury in Former Yugoslav Republic of Macedonia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pelvic organ prolapse and urogynecological assessment in women with spinal cord injury

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Differences in Acute Metabolic Responses to Bionic and Nonbionic Ambulation in Spinal Cord Injured Humans and Controls

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Epidemiological characteristics and early complications after spinal cord injury in Former Yugoslav Republic of Macedonia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. International Perspectives on Spinal Cord Injury Care

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

Vis graf over relationer

STUDY DESIGN: Retrospective chart study.

OBJECTIVES: The aim was to examine continuation of treatment of individuals with spinal cord injury including myelomeningocele and neurogenic detrusor overactivity, treated with repeated intra-detrusor Botulinum toxin A injections, and to investigate factors associated with discontinuation of treatment.

SETTING: Rigshospitalet, Denmark METHODS: This study included 128 individuals with spinal cord injury and neurogenic detrusor overactivity, who were offered repeated Botulinum toxin A injections between 2001 and 2018. Continuation rates of the treatment were estimated using Kaplan Meier analysis. A Cox proportional hazard analysis was used to investigate factors predictive of discontinuation.

RESULTS: A total of 1156 treatments were performed. The median number of treatments was six (IQR 9, range 1-51), and median follow-up was 10.6 years (IQR 8.5, range 0-16.9). All urodynamic parameters changed significantly after the first treatment (p < 0.001). The continuation group had significantly higher mean maximum bladder capacity after the first injections compared with the discontinuation group, with a mean difference between the groups of 84.5 mL (95% CI 4.7-164.2) (p = 0.038). The probability of continuing treatments after 5 years was 59% (95% CI 50.0-67.8) and 50% (95% CI 40.1-59.3) after 10 years. Individuals aged 31-50 years were more likely to continue treatment compared with those aged >50 years (95% CI 0.21‒0.79) (p = 0.008). No other factors predicted discontinuation.

CONCLUSIONS: This long-term follow-up study showed that 50% of people with spinal cord injury starting intra-detrusor Botulinum toxin A for neurogenic detrusor overactivity are still receiving injections after 10 years.

OriginalsprogEngelsk
TidsskriftSpinal Cord
Vol/bind58
Udgave nummer6
Sider (fra-til)675-681
Antal sider7
ISSN1362-4393
DOI
StatusUdgivet - jun. 2020

ID: 60880018